Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel

The lack of targeted therapies for triple-negative breast cancer (TNBC) contributes to their high mortality rates and high risk of relapse compared to other subtypes of breast cancer. Most TNBCs (75%) have downregulated the expression of CREB3L1 (cAMP-responsive element binding protein 3 like 1), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Plett, Riley, Mellor, Paul, Kendall, Stephanie, Hammond, S. Austin, Boulet, Aren, Plaza, Kristine, Vizeacoumar, Frederick S., Vizeacoumar, Franco J., Anderson, Deborah H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485251/
https://www.ncbi.nlm.nih.gov/pubmed/36123435
http://dx.doi.org/10.1038/s41598-022-19621-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485251/
https://www.ncbi.nlm.nih.gov/pubmed/36123435
http://dx.doi.org/10.1038/s41598-022-19621-7

Ejemplares similares